GlycoMimetics Correlations
GLYC Stock | USD 0.32 0.01 3.03% |
The current 90-days correlation between GlycoMimetics and AN2 Therapeutics is -0.02 (i.e., Good diversification). The correlation of GlycoMimetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
GlycoMimetics Correlation With Market
Good diversification
The correlation between GlycoMimetics and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding GlycoMimetics and DJI in the same portfolio, assuming nothing else is changed.
GlycoMimetics |
Moving together with GlycoMimetics Stock
0.77 | MDGL | Madrigal Pharmaceuticals | PairCorr |
0.7 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
Moving against GlycoMimetics Stock
0.76 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.74 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.73 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.68 | ME | 23Andme Holding | PairCorr |
0.68 | MTEM | Molecular Templates | PairCorr |
0.66 | NKTX | Nkarta Inc | PairCorr |
0.65 | AGL | agilon health | PairCorr |
0.64 | TPST | Tempest Therapeutics | PairCorr |
0.61 | TCHH | Trustcash Holdings | PairCorr |
0.6 | IPSC | Century Therapeutics | PairCorr |
0.57 | A | Agilent Technologies Earnings Call This Week | PairCorr |
0.42 | VALN | Valneva SE ADR | PairCorr |
0.87 | KO | Coca Cola Aggressive Push | PairCorr |
0.82 | HYMTF | Hyundai Motor | PairCorr |
0.79 | TLK | Telkom Indonesia Tbk | PairCorr |
0.61 | SHG | Shinhan Financial | PairCorr |
0.61 | EC | Ecopetrol SA ADR | PairCorr |
0.58 | WF | Woori Financial Group | PairCorr |
0.57 | PG | Procter Gamble | PairCorr |
0.42 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
0.35 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between GlycoMimetics Stock performing well and GlycoMimetics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GlycoMimetics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
MLYS | 2.68 | (0.08) | 0.03 | 0.09 | 3.37 | 6.27 | 20.98 | |||
FHTX | 4.06 | (0.21) | 0.02 | 0.06 | 4.43 | 8.50 | 34.64 | |||
IVA | 3.33 | 0.29 | 0.04 | 1.13 | 4.09 | 7.26 | 49.76 | |||
DYN | 3.10 | (0.80) | 0.00 | (0.20) | 0.00 | 5.70 | 32.99 | |||
LIFE | 2.57 | 0.46 | 0.09 | (0.82) | 2.62 | 6.45 | 28.98 | |||
TRVI | 3.18 | (0.08) | 0.01 | 0.08 | 3.64 | 7.37 | 17.04 | |||
CUE | 7.62 | 0.99 | 0.15 | 1.10 | 5.86 | 20.27 | 67.78 | |||
ANTX | 1.88 | 0.19 | 0.06 | 0.32 | 1.89 | 2.88 | 28.03 | |||
BCAB | 4.34 | (0.33) | 0.00 | (0.07) | 0.00 | 12.86 | 31.41 |
GlycoMimetics Corporate Executives
Elected by the shareholders, the GlycoMimetics' board of directors comprises two types of representatives: GlycoMimetics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GlycoMimetics. The board's role is to monitor GlycoMimetics' management team and ensure that shareholders' interests are well served. GlycoMimetics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GlycoMimetics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Brian Hahn | CFO and Principal Accounting Officer | Profile |